Perissutti B - Search Results

1

Overcoming the Drawbacks of Sulpiride by Means of New Crystal Forms.

Birolo R, Bravetti F, Bordignon S, D'Abbrunzo I, Mazzeo PP, Perissutti B, Bacchi A, Chierotti MR, Gobetto R. Birolo R, et al. Among authors: perissutti b. Pharmaceutics. 2022 Aug 23;14(9):1754. doi: 10.3390/pharmaceutics14091754. Pharmaceutics. 2022. PMID: 36145502 Free PMC article.

2

Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution.

Moneghini M, Kikic I, Voinovich D, Perissutti B, Filipović-Grcić J. Moneghini M, et al. Among authors: perissutti b. Int J Pharm. 2001 Jul 3;222(1):129-38. doi: 10.1016/s0378-5173(01)00711-6. Int J Pharm. 2001. PMID: 11404039

3

Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique.

Perissutti B, Rubessa F, Moneghini M, Voinovich D. Perissutti B, et al. Int J Pharm. 2003 Apr 30;256(1-2):53-63. doi: 10.1016/s0378-5173(03)00062-0. Int J Pharm. 2003. PMID: 12695011

4

Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies.

Hasa D, Voinovich D, Perissutti B, Grassi M, Bonifacio A, Sergo V, Cepek C, Chierotti MR, Gobetto R, Dall'Acqua S, Invernizzi S. Hasa D, et al. Among authors: perissutti b. Pharm Res. 2011 Aug;28(8):1870-83. doi: 10.1007/s11095-011-0415-8. Epub 2011 Mar 19. Pharm Res. 2011. PMID: 21424156

5

Mechanochemically induced disordered structures of vincamine: the different mediation of two cross-linked polymers.

Hasa D, Perissutti B, Chierotti MR, Gobetto R, Grabnar I, Bonifacio A, Dall'Acqua S, Invernizzi S, Voinovich D. Hasa D, et al. Among authors: perissutti b. Int J Pharm. 2012 Oct 15;436(1-2):41-57. doi: 10.1016/j.ijpharm.2012.06.024. Epub 2012 Jun 19. Int J Pharm. 2012. PMID: 22721852

6

Drug salt formation via mechanochemistry: the case study of vincamine.

Hasa D, Perissutti B, Cepek C, Bhardwaj S, Carlino E, Grassi M, Invernizzi S, Voinovich D. Hasa D, et al. Among authors: perissutti b. Mol Pharm. 2013 Jan 7;10(1):211-24. doi: 10.1021/mp300371f. Epub 2012 Dec 6. Mol Pharm. 2013. PMID: 23186380

7

Rationale of using Vinca minor Linne dry extract phytocomplex as a vincamine's oral bioavailability enhancer.

Hasa D, Perissutti B, Dall'Acqua S, Chierotti MR, Gobetto R, Grabnar I, Cepek C, Voinovich D. Hasa D, et al. Among authors: perissutti b. Eur J Pharm Biopharm. 2013 May;84(1):138-44. doi: 10.1016/j.ejpb.2012.11.025. Epub 2012 Dec 11. Eur J Pharm Biopharm. 2013. PMID: 23238273

8

Mechanochemical activation of vincamine mediated by linear polymers: assessment of some "critical" steps.

Hasa D, Perissutti B, Grassi M, Chierotti MR, Gobetto R, Ferrario V, Lenaz D, Voinovich D. Hasa D, et al. Among authors: perissutti b. Eur J Pharm Sci. 2013 Sep 27;50(1):56-68. doi: 10.1016/j.ejps.2013.03.003. Epub 2013 Mar 21. Eur J Pharm Sci. 2013. PMID: 23524254

9

Nanostructured Drugs Embedded into a Polymeric Matrix: Vinpocetine/PVP Hybrids Investigated by Debye Function Analysis.

Hasa D, Giacobbe C, Perissutti B, Voinovich D, Grassi M, Cervellino A, Masciocchi N, Guagliardi A. Hasa D, et al. Among authors: perissutti b. Mol Pharm. 2016 Sep 6;13(9):3034-42. doi: 10.1021/acs.molpharmaceut.6b00124. Epub 2016 Jul 28. Mol Pharm. 2016. PMID: 27428180

10

A new soluble and bioactive polymorph of praziquantel.

Zanolla D, Perissutti B, Passerini N, Chierotti MR, Hasa D, Voinovich D, Gigli L, Demitri N, Geremia S, Keiser J, Cerreia Vioglio P, Albertini B. Zanolla D, et al. Among authors: perissutti b. Eur J Pharm Biopharm. 2018 Jun;127:19-28. doi: 10.1016/j.ejpb.2018.01.018. Epub 2018 Jan 31. Eur J Pharm Biopharm. 2018. PMID: 29409939 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page